The company is engaged in issuing bonds and depositing the proceeds with Clal Insurance.
Clal Capital Raising is not an earnings story but a market-access story: 2025 showed that it can still replace and extend funding for Clal Insurance, but it also pushed part of the structure into a more loss-absorbing layer through Series XV.
Clal Capital Raising's post-2030 wall is mainly a refinancing wall built on assumed early redemption dates rather than a hard legal stop. The 2025 actions and the January 2026 reopening bought time and proved market access, but mainly by postponing and concentrating the real tes…
Series XV now sits at the center of Clal Capital Raising's credit story because the group's marginal funding increasingly runs through an Additional Tier 1 instrument where coupon cancellation, principal deferral, principal write-down, and a 2036 reset window are core economics…
